HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yasuhiro Fujiwara Selected Research

tofisopam

3/2016Disorder of autonomic nervous system and its vulnerability to external stimulation in functional dyspepsia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yasuhiro Fujiwara Research Topics

Disease

93Neoplasms (Cancer)
12/2021 - 12/2004
72Breast Neoplasms (Breast Cancer)
10/2021 - 12/2004
28Gastroesophageal Reflux (GERD)
01/2022 - 05/2004
26Neoplasm Metastasis (Metastasis)
04/2021 - 06/2008
22Ulcer
06/2022 - 07/2002
22Ulcerative Colitis
06/2022 - 09/2003
19Hemorrhage
07/2022 - 01/2008
17Infections
02/2022 - 07/2002
15Pathologic Constriction (Stenosis)
06/2022 - 08/2004
15Crohn Disease (Crohn's Disease)
02/2022 - 09/2003
14Inflammation (Inflammations)
01/2022 - 01/2004
13Stomach Neoplasms (Stomach Cancer)
04/2021 - 10/2005
13Disease Progression
01/2020 - 02/2005
12Peptic Esophagitis (Reflux Esophagitis)
01/2022 - 01/2003
10Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
06/2022 - 09/2003
10Carcinoma (Carcinomatosis)
12/2020 - 09/2005
10Stomach Ulcer (Gastric Ulcer)
05/2013 - 07/2002
9Esophagitis
01/2022 - 01/2003
8Adenocarcinoma
10/2020 - 04/2005
7COVID-19
05/2022 - 06/2021
7Lung Neoplasms (Lung Cancer)
01/2022 - 09/2004
7Esophageal Neoplasms (Esophageal Cancer)
01/2021 - 12/2008
7Triple Negative Breast Neoplasms
06/2020 - 04/2012
7Heartburn (Pyrosis)
03/2015 - 01/2005
6Dysbiosis
05/2022 - 01/2017
6Non-Erosive Reflux Disease
01/2022 - 11/2011
6Eosinophilic Esophagitis
01/2022 - 01/2019
6Diarrhea
01/2021 - 08/2002
6Ovarian Neoplasms (Ovarian Cancer)
12/2020 - 06/2009
6Pathologic Complete Response
12/2019 - 09/2005
6Wounds and Injuries (Trauma)
01/2017 - 10/2004
6Brain Neoplasms (Brain Tumor)
01/2015 - 11/2008
6Peptic Ulcer (Peptic Ulcers)
03/2013 - 09/2002
5Pain (Aches)
04/2021 - 01/2011
5Rheumatoid Arthritis
01/2017 - 01/2008
5Carcinogenesis
02/2016 - 01/2010
4Esophageal Stenosis (Esophageal Stricture)
06/2022 - 04/2016
4Sleep Initiation and Maintenance Disorders (Insomnia)
10/2021 - 01/2016
4Endometrial Neoplasms (Endometrial Cancer)
10/2021 - 08/2005
4Colitis
09/2021 - 12/2008
4Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 11/2010
4Dyspepsia (Indigestion)
12/2020 - 09/2015
4Interstitial Lung Diseases (Interstitial Lung Disease)
03/2020 - 01/2014

Drug/Important Bio-Agent (IBA)

27Proton Pump InhibitorsIBA
01/2021 - 03/2004
25AcidsIBA
01/2022 - 01/2003
21Pharmaceutical PreparationsIBA
06/2022 - 07/2002
17Trastuzumab (Herceptin)FDA Link
01/2020 - 01/2009
15Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
04/2021 - 08/2002
15Paclitaxel (Taxol)FDA LinkGeneric
10/2019 - 02/2005
14Proteins (Proteins, Gene)FDA Link
06/2022 - 05/2004
14Messenger RNA (mRNA)IBA
12/2021 - 01/2003
13Biomarkers (Surrogate Marker)IBA
05/2022 - 11/2005
13human ERBB2 proteinIBA
10/2021 - 08/2009
13ErbB Receptors (EGF Receptor)IBA
10/2020 - 11/2005
13Hormones (Hormone)IBA
01/2020 - 12/2004
12CytokinesIBA
01/2022 - 01/2003
12taxaneIBA
04/2020 - 09/2005
11AnthracyclinesIBA
01/2020 - 09/2005
11Capsules (Microcapsules)IBA
10/2018 - 07/2006
9Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2022 - 01/2003
9Cisplatin (Platino)FDA LinkGeneric
12/2021 - 08/2005
9Estrogen ReceptorsIBA
07/2017 - 11/2008
8Monoclonal AntibodiesIBA
04/2021 - 12/2004
8Fluorouracil (Carac)FDA LinkGeneric
01/2021 - 01/2004
8PlatinumIBA
05/2012 - 09/2005
7Rabeprazole (Aciphex)FDA Link
02/2021 - 01/2003
7Carboplatin (JM8)FDA LinkGeneric
11/2017 - 09/2005
7rebamipideIBA
09/2015 - 07/2002
7Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2014 - 08/2005
6SteroidsIBA
06/2022 - 03/2008
6InflammasomesIBA
06/2022 - 07/2016
6Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
02/2021 - 11/2008
6Infliximab (Remicade)FDA Link
03/2018 - 03/2014
6Biological ProductsIBA
01/2018 - 10/2004
6DenosumabFDA Link
11/2017 - 06/2008
6Progesterone Receptors (Progesterone Receptor)IBA
07/2017 - 10/2007
6AntigensIBA
01/2012 - 01/2003
5Acetic Acid (Vinegar)FDA LinkGeneric
06/2022 - 07/2002
5Indomethacin (Indometacin)FDA LinkGeneric
01/2021 - 01/2004
5eribulinFDA Link
06/2020 - 12/2017
5Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
05/2020 - 01/2004
5ProstaglandinsIBA
05/2020 - 02/2010
4Therapeutic UsesIBA
06/2022 - 12/2008
41- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA
01/2022 - 01/2017
4NivolumabIBA
04/2021 - 01/2018
4Dinoprostone (PGE2)FDA Link
03/2021 - 01/2004
4Misoprostol (Cytotec)FDA LinkGeneric
02/2021 - 06/2011
4Tacrolimus (Prograf)FDA LinkGeneric
01/2021 - 09/2017
4EnzymesIBA
01/2021 - 09/2003
4MicroRNAs (MicroRNA)IBA
12/2020 - 03/2016
4IfosfamideFDA LinkGeneric
10/2019 - 01/2010

Therapy/Procedure

92Therapeutics
06/2022 - 09/2002
51Drug Therapy (Chemotherapy)
01/2022 - 09/2005
17Neoadjuvant Therapy
12/2021 - 09/2005
8Aftercare (After-Treatment)
12/2021 - 10/2002
7Radiotherapy
01/2022 - 01/2007
5Hepatectomy
12/2021 - 08/2011
5Lasers (Laser)
05/2021 - 10/2017
5Adjuvant Chemotherapy
05/2015 - 07/2007
4Gastrectomy
01/2022 - 11/2011